Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vasopressin V2 receptor (Rattus norvegicus (Rat)) | BDBM50125101 (Biphenyl-2-carboxylic acid [4-(1,3,4,5-tetrahydro-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Binding affinity towards V2 receptor | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V2 receptor (Homo sapiens (Human)) | BDBM50065115 (3-chloro-4-(10,11-dihydro-5H-benzo[e]pyrrolo[1,2-a...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Displacement of [3H]-AVP from human V2 receptors expressed in HEK-293 cells | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V2 receptor (Homo sapiens (Human)) | BDBM50125112 (Biphenyl-2-carboxylic acid [4-(2-oxo-1,2,2a,3,4,5-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents | PubMed | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Displacement of [3H]-AVP from human V2 receptors expressed in HEK-293 cells | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V2 receptor (Homo sapiens (Human)) | BDBM50125103 (4'-Methyl-biphenyl-2-carboxylic acid [4-(1,3,4,5-t...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Displacement of [3H]-AVP from human V2 receptors expressed in HEK-293 cells | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V2 receptor (Homo sapiens (Human)) | BDBM50125107 (6-{4-[(Biphenyl-2-carbonyl)-amino]-3-chloro-benzoy...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Displacement of [3H]-AVP from human V2 receptors expressed in HEK-293 cells | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V2 receptor (Homo sapiens (Human)) | BDBM50125108 (6-{4-[(Biphenyl-2-carbonyl)-amino]-benzoyl}-3,4,5,...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Displacement of [3H]-AVP from human V2 receptors expressed in HEK-293 cells | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V2 receptor (Homo sapiens (Human)) | BDBM50125106 (Biphenyl-2-carboxylic acid [2-chloro-4-(1,3,4,5-te...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Displacement of [3H]-AVP from human V2 receptors expressed in HEK-293 cells | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V2 receptor (Homo sapiens (Human)) | BDBM50125101 (Biphenyl-2-carboxylic acid [4-(1,3,4,5-tetrahydro-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Displacement of [3H]-AVP from human V2 receptors expressed in HEK-293 cells | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V2 receptor (Homo sapiens (Human)) | BDBM50125105 (Biphenyl-2-carboxylic acid [4-(2-chloro-1,3,4,5-te...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 44 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Displacement of [3H]-AVP from human V2 receptors expressed in HEK-293 cells | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V2 receptor (Homo sapiens (Human)) | BDBM50125100 (Biphenyl-2-carboxylic acid [3-chloro-4-(1,3,4,5-te...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Inhibitory activity of the human V2 receptor was assessed by the accumulation of cAMP in transfected HEK-293 cells. | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V2 receptor (Homo sapiens (Human)) | BDBM50125101 (Biphenyl-2-carboxylic acid [4-(1,3,4,5-tetrahydro-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Inhibitory activity of the human V2 receptor was assessed by the accumulation of cAMP in transfected HEK-293 cells. | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V2 receptor (Homo sapiens (Human)) | BDBM50125103 (4'-Methyl-biphenyl-2-carboxylic acid [4-(1,3,4,5-t...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Inhibitory activity of the human V2 receptor was assessed by the accumulation of cAMP in transfected HEK-293 cells. | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V2 receptor (Homo sapiens (Human)) | BDBM50065115 (3-chloro-4-(10,11-dihydro-5H-benzo[e]pyrrolo[1,2-a...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 91 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Inhibitory activity of the human V2 receptor was assessed by the accumulation of cAMP in transfected HEK-293 cells. | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1a receptor (Homo sapiens (Human)) | BDBM50065115 (3-chloro-4-(10,11-dihydro-5H-benzo[e]pyrrolo[1,2-a...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Binding affinity towards human V1a receptors | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V2 receptor (Homo sapiens (Human)) | BDBM50125111 (4'-Methyl-biphenyl-2-carboxylic acid [4-(1-acetyl-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Displacement of [3H]-AVP from human V2 receptors expressed in HEK-293 cells | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V2 receptor (Homo sapiens (Human)) | BDBM50125102 (3-Fluoro-2-methyl-N-[4-(1,3,4,5-tetrahydro-azepino...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Displacement of [3H]-AVP from human V2 receptors expressed in HEK-293 cells | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V2 receptor (Homo sapiens (Human)) | BDBM50125110 (5-Fluoro-2-methyl-N-[4-(1,3,4,5-tetrahydro-azepino...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 190 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Displacement of [3H]-AVP from human V2 receptors expressed in HEK-293 cells | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V2 receptor (Homo sapiens (Human)) | BDBM50125104 (4'-Methyl-biphenyl-2-carboxylic acid [4-(1-methyl-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 210 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Displacement of [3H]-AVP from human V2 receptors expressed in HEK-293 cells | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V2 receptor (Homo sapiens (Human)) | BDBM50125100 (Biphenyl-2-carboxylic acid [3-chloro-4-(1,3,4,5-te...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 330 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Inhibitory activity of the human V2 receptor was assessed by the accumulation of cAMP in transfected HEK-293 cells. | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V2 receptor (Homo sapiens (Human)) | BDBM50125109 ((6-{4-[(4'-Methyl-biphenyl-2-carbonyl)-amino]-benz...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Displacement of [3H]-AVP from human V2 receptors expressed in HEK-293 cells | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1a receptor (Homo sapiens (Human)) | BDBM50125101 (Biphenyl-2-carboxylic acid [4-(1,3,4,5-tetrahydro-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 3.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL | Assay Description Binding affinity towards VIa receptor | Bioorg Med Chem Lett 13: 753-6 (2003) BindingDB Entry DOI: 10.7270/Q2DZ07PV | |||||||||||
More data for this Ligand-Target Pair |